Cryosurgery/cryoablation in musculoskeletal neoplasms: history and state of the art
Author:
Publisher
Springer Science and Business Media LLC
Subject
Orthopedics and Sports Medicine
Link
http://link.springer.com/content/pdf/10.1007/s12178-015-9307-6.pdf
Reference24 articles.
1. Marcove RC, Miller TR. The treatment of primary and metastatic localized bone tumors by cryosurgery. Surg Clin N Am. 1969;49:421–30.
2. Meller I, Weinbroum A, Bickels J, et al. Fiftenn years of bone tumor cryosurgery: a single center experience of 440 procedures and long-term follow-up. Eur J Surg Oncol. 2008;34:921–7.
3. Veth R, Schreuder B, van Beem H, et al. Cryosurgery in aggressive, benign, and low-grade malignant bone tumors. Lancet Oncol. 2005;6:25–34.
4. Gage AA, Baust JC. Cryosurgery for tumors. J Am Coll Surg. 2007;205:342–56.
5. Callstrom MR, Kurup AN. Percutaneous ablation for bone and soft tissue metastases—why cryoablation? Skelet Radiol. 2009;38:835–9. While published in 2009, this article remains current and outlines the rationale and indications for considering cryoablation of musculeoskeletal metastatic disease.
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Utility of Intraoperative Neuromonitoring to Protect against Adjacent Nerve Injury in Musculoskeletal and Lymph Nodal Cryoablation;Journal of Vascular and Interventional Radiology;2024-07
2. Economic evaluation of percutaneous cryoablation vs conventional surgery in extra-abdominal desmoid tumours in the Spanish healthcare system;Insights into Imaging;2024-01-07
3. Cementoplasty to cryoablation: review and current status;BJR|Open;2023-12-12
4. Argon-helium knife cryoablation plus programmed cell death protein 1 inhibitor in the treatment of advanced soft tissue sarcomas: there is no evidence of the synergistic effects of this combination therapy;Frontiers in Oncology;2023-09-05
5. Functional tumor cell-intrinsic STING, not host STING, drives local and systemic antitumor immunity and therapy efficacy following cryoablation;Journal for ImmunoTherapy of Cancer;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3